GelMEDIX
PrivateLast Round
Seed Round
Apr 30, 2026
Total Funding Raised
$34.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GelMEDIX is a biotechnology company developing regenerative therapies that restore vision by regenerating damaged retinal cells using a proprietary injectable hydrogel scaffold platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GelMEDIX Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
GelMEDIX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 30, 2026 | ||||
| Seed | Feb 17, 2026 | ||||
| VC Round | Jan 8, 2026 | ||||
| Seed | Oct 20, 2025 | ||||
| Debt | Mar 26, 2024 | ||||
Series A | Aug 9, 2022 |
Key People
Founding team and executive leadership
GelMEDIX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TiE Boston | Seed |
| Beacon Angels | Seed |
| Safar Partners | Series A, Seed |
| TiE Boston Angels | Seed |
| Boston Harbor Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
$747K raised in Seed Round.
- Feb 17, 2026
$13M round led by Safar Partners.
GelMEDIX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GelMEDIX's valuation, stock price, and market status.